TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

INSP STOCK NOTICE: Inspire Medical Systems, Inc. Inspire V Delays Lead to Securities Class Action – Contact BFA Law before January 5 Legal Deadline

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bleichmar Fonti & Auld Llp
INSP STOCK NOTICE: Inspire Medical Systems, Inc. Inspire V Delays Lead to Securities Class Action – Contact BFA Law before January 5 Legal Deadline

A securities class action has been filed against Inspire Medical Systems (NYSE: INSP) for alleged fraud related to significant delays in the Inspire V device launch. The company failed to adequately prepare clinicians and payors for rollout, and faced weak demand due to customer inventory backlog. On August 5, 2025, Inspire stock dropped 32% after the company disclosed the elongated launch timeline and reduced 2025 earnings guidance by over 80%. Investors have until January 5, 2026, to join the lawsuit.

Insights
BMLpL   neutral

Buffett trimmed the position by 26.3 million shares, suggesting a measured approach to the financial sector


INSP   negative

The company faces a securities class action lawsuit for alleged fraud related to misrepresenting Inspire V launch readiness. Stock dropped 32% following disclosure of significant delays, weak demand, and an 80%+ reduction in earnings guidance. Multiple operational failures including inadequate clinician preparation and software delays contributed to poor device adoption.